318 - Development of AVID200, a novel TGF-β targeting immunotherapy: Characterization of immunomodulatory effects
| Autor: | O'Connor-McCourt, M., Lenferink, A., Zwaagstra, J., Sulea, T., Weeratna, R., Maleki, S., Baardsnes, J., Collins, C., Cantin, C., Durocher, Y., Singh, R., Figueredo, R., Krishnan, L., Koropatnick, J., Tikhomirov, I. |
|---|---|
| Zdroj: | In European Journal of Cancer December 2016 69 Supplement 1:S105-S105 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect